Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00360945Phase 2Unknown
A Phase 2 trial of cisplatin, temozolomide in malignant glioma, sponsored by Children's Cancer and Leukaemia Group. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00360945.